The Modern Concept of Development of Vaccine Prevention in Russia
https://doi.org/10.31631/2073-3046-2019-18-5-4-13
Abstract
This paper reviews concept issues of vaccination in Russian Federation. There are three periods of vaccination history. The provisions of the concept were formulated on the basis of the results of multi-year researches and analysis of data from domestic and foreign studies. Main provisions aim at: reconstruction of domestic vaccine production; improvement of the national immunization schedule and public policy for country biosafety; promotion of the WHO strategy for full immunization throughout life in Russia; development of the national immunization schedule for adults and monitoring system for adverse events following immunization; implementation of vaccination risk management and epidemiological surveillance for disease prevention, improvement of vaccination compliance among people, health care workers, mass media, legislative and executive authorities. Implementation of the provisions of the modern vaccination concept in Russia would contribute to solving demographic problems, to reduce morbidity and mortality, to promote active aging, and would have a significant economic effect.
About the Authors
N. I. Briko
Sechenov University; Central Research Institute of Epidemiology Moscow
Russian Federation
Russian Federation
Nikolaj I. Briko – academician of the Russian Academy of Sciences, Dr. Sci. (Med.), professor, Director of the Institute of Public Health and Head of the Department of Epidemiology and Evidence-Based Medicine of Sechenov University.
B. Pirogovskaya, 2, 2. Moscow, 119435.
+7 (499) 248 04 13.
Author ID-7004344976
I. V. Feldblyum
Perm State Medical University named after Academician E.A. Wagner
Russian Federation
Russian Federation
Irina V.iktorovna Feldblyum – Dr. Sci. (Med.), professor, Head of the Department of Epidemiology of Perm State Medical University named after Academician E.A. Wagner.
26 Petropavlovskaya St., Perm, 614990.
+7(342) 218-16-68.
References
1. Briko N.I., Feldblyum I.V. Immunoprophylaxis of Infectious Diseases in Russia: Status and Prospects for Improvement Epidemiology and Vaccinal Prevention. 2017; 2(93): 4–10. (In Russ.).
2. Pokrovsky V.I., Semenov B.F. Inactivated influenza vaccine protects against heart attacks and strokes during the epidemic rise of influenza // Vaccine prevention of noncommunicable diseases. 2004; 4(34). (In Russ.).
3. Feldblyum I.V. Naumov O. Yu., Devyatkov M.Yu. et al. Vaccination against influenza as a tool for managing the risk of mortality from diseases of the circulatory system. Epidemiology and Vaccinal Prevention. 2011; 1(56): 64–67. (In Russ.).
4. Briko N.I., Feldblyum I.V. Vaccinoprophylaxis: status and prospects for further development. Federal Directory of Russian Health . –ANO «Center for Strategic Programs». Moscow. 2017; 167–169. (In Russ.).
5. Subbotina K.A., Feldblyum I.V., Kochergina E.A. et al. Epidemiological rationale for changing strategies and tactics for specific pertussis prophylaxis in modern conditions. Epidemiology and Vaccinal Prevention. 2019; 18 (2): 27–33 https: // doi: 10.31631/2073-3046-2019-18-2-2-27-33. (In Russ.).
6. Skoff T.H., Kenyon C., Cocoros N., et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015; 4(136): 635–641.
7. Wendelboe A.M. et al. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerging themes in epidemiology. 2007; 1(4): 15.
8. Mindlina A.Ya., Polybin R.V. On the need to improve the tactics of immunization of whooping cough. Pulmonology. 2016; 5(26): 560–569. (In Russ.).
9. World Health Organization et al. Pertussis vaccines: WHO position paper– September 2015. 28 August 2015; 90(35): 433–460.
10. Maltezou H.C., Ftika L., Theodoridou M. Nosocomial pertussis in neonatal units. Journal of Hospital Infection. 2013; 4(85): 243–248.
11. Matosova S.V. and others. Molecular biological monitoring of pathogens of purulent bacterial meningitis at the present stage. Infectious diseases: News. Opinions. Training. 2018; 1(7): 24. (In Russ.).
12. Koroleva I.S., Beloshitsky G.V., Zakroeva I.M. et al. Meningococcal infection in the Russian Federation. Medical Alphabet. Epidemiology and Hygiene. 2015; 6(1): 27–28. (In Russ.).
13. Kostyukova N.N., Behalo V.A., Chernyshova T.F. Meningococcal infection in Russia: past and immediate prospects. Epidemiology and Infectious Diseases. Actual issues. 2014; 2: 73–79. (In Russ.).
14. Koroleva M.A. Epidemiological monitoring of purulent bacterial meningitis in the Russian Federation: author. dis. ... cand. medical science. M. 2014; 22. (In Russ.).
15. Harrison L.H., Trotter C.L., Ramsay M.E. Global epidemiology of meningococcal disease. Vaccine. 2009; 24: 51–63.
16. Flexner S., Jobling J.W. An analysis of four hundred cases of epidemic meningitis treated with the anti-meningitis serum. J. Exp. Med. 1908; 5(10): 690–733
17. SP 3.1.3542-18 «Prevention of meningococcal infection». (In Russ.).
18. Feldblum I.V. Modern problems of vaccine prophylaxis (scientific review). Preventive and clinical medicine. 2017; 2: 20–27. (In Russ.).
19. Sergeeva I.V., Lipnyagova S.V., Bekert A.I. et al. Modern features of the course of chickenpox. Modern problems of science and education. 2015; 5: 202–202. (In Russ.).
20. Zryachkin N.I., Buchkova T.N., Chebotareva G.I. Complications of chickenpox (literature review). Journal of Infectology. 2017; 3(9): 117–128. (In Russ.).
21. Kokoreva S.P., Ilunina L.M., Kazartseva N.V. Clinic and course of chickenpox in modern conditions. Treatment and Prevention. 2016; 4: 13–20. (In Russ.).
22. Betta M. et al. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proceedings of the Royal Society B: Biological Sciences. 2016; 1826(283): 20160054.
23. Poletti P. et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PloS one. 2013; 4(8): e60732.
24. Baranov А.А., Namazova-Baranova L.S Rotavirus infection in children is an unresolved problem. Review of recommendations for vaccine prevention. 2017; 248. (In Russ.).
25. Katherine L. Rosettieet al. Indirect Rotavirus Vaccine Effectiveness for the Prevention of Rotavirus Hospitalization: A Systematic Review and Meta-Analysis Am. J. Trop. Med. Hyg. 2018; 98(4): 1197–1201.
26. Babik R.K., Korneeva E.V. Clinical and immunological features of rotavirus infection in children. Man. Sport. Medicine. 2011; 3: 58. (In Russ.).
27. Andrew Clark, et al. Estimating global, regional, and national rotavirus deaths in children under <5 years, 2017. Clin Infect Dis. 2017
28. Eric S. Weintraubet. al. Risk of Intussusception after Monovalent Rotavirus Vaccination; The New England journal of Medicine 2014; 370: 513–9.
29. Gabriel Chiaet. et. al. An unusual outbreak of rotavirus G8P [8] gastroenteritis in adults in an urban community, Singapore, 2016. Journal of Clinical Virology. 2018; 105: 57–63.
30. Disai F.J., Chrisman W.T. Clinical oncogynecology. In 3 t. Per. from English Clinical Oncogynecology: Reed Elsiver Publishing House. 2012; 1: 316.
31. Clifford G, Franceschi S, Plummer M, De Martel C. The burden of HPV associated cancers in men and women. Eurogin. 2016; 2–3.
32. De Sanjose S. The state of the art of HPV epidemiology, cervical vs oral. Eurogin. 2016; 4–5.
33. Hall M.T. et al. The projected timeframe until cervical cancer elimination in Australia: a modellingstudy. The Lancet Public Health. 2019; 1(4): e19-e27.
34. Briko N.I., Lopukhov P.D., Kaprin A.D., et al. HPV-asso:ciated lesions in the Russian Federation: assessment of the problem. Journal of Modern Oncology. 2019; 21(1): 45–50 DOI: 10.26442/18151434.2019.190199. (In Russ.).
35. Kaprin A.D., Starinskij V.V., Petrova G.V. Zlokachestvennye novoobrazovanija v Rossii v 2017 godu (zabolevaemost ‘i smertnost’) [Malignancies in Russia in 2017 (morbidity and mortality)]. Moscow: Moskovskiy nauchno-issledovatel’skiy onkologicheskiy institut im. P.A. Gertsena - filial FGU «NMIRС » Minzdrava Rossii, 2018; 250. (In Russ.).
36. Barchuk A, Bespalov A, Huhtala H, et al. Breast and cervical cancer incidence and mortality trends in Russia 1980–2013. Cancer Epidemiol. 2018 Aug; 55: 73–80 DOI: 10.1016/j.canep.2018.05.008.
37. Simms K.T. et al. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modellingstudy. The Lancet Oncology. 2019; 3(20): 394–407.
38. https://www.who.int/en/emergencies/ten-threats-to-global-health-in-2019.
39. Institute for Health Measurement and Health Assessment, Human Development Network, World Bank. The global burden of disease: the generation of evidence policy direction – regional publication for Europe and Central Asia. Seattle, WA: IHME; 2013.
40. World report on aging and health. World Health Organization, 2016. Available at: ttp://apps.who.int/iris/bitstream/10665/186463/10/9789244565049_eng.pdf?ua=. (In Russ.).
41. Noncommunicable diseases. WHO Newsletter, April 2017 Available at: http://www.who.int/mediacentre/factsheets/fs355/en/ Link active on 01/22/2018.
42. HIV/AIDS. Newsletter, July 2017. Available at: http://www.who.int/mediacentre/factsheets/fs360/en/ Link active on 01/22/2018
43. Briko N.I., Tsapkova N.N., Batyrshina L.R., et al. Problems of vaccine prophylaxis of the adult population. Epidemiology and Vaccinal Prevention. 2018; 2(99): 4–15. (In Russ.).
44. Briкo N.I., Feldblyum I.V. Subbotina K.A. et al. Vaccine prevention of infectious diseases in adults. Journal of Infectology. 2018; 2: 5–16. (In Russ.).
45. Labor and employment in Russia. 2017: Statistically compilation. Rosstat-T. 78 Moscow. 2017. (In Russ.).
46. Briko N.I., Namazova-Baranova L.S., Lobzin Yu.V. et al. Improving the monitoring of adverse events in the post-vaccination period (in discussion order). Epidemiology and Vaccinal Prevention. – 2016; 6 (91). (In Russ.).
47. Feldblyum I.V. Risk management in the field of vaccine prevention as one of the directions for ensuring epidemiological and biological safety. Epidemiology and Vaccinal Prevention. 2018; 5(102). (In Russ.).
48. Larson H.J. et al. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016; 12: 295–301.
49. Feldblyum I.V., Perminova O.A., Koryukina I.P. Tactics of immunizing children against diphtheria in areas of environmental risk. Russian Pediatric Journal. 1999; 4: 42–44. (In Russ.).
50. Kaplina S.P., Skripchenko N.V., Harit S.M. Vaccination tactics for children with neurological disorders. In the book: Neuroinfections in children. St. Petersburg. 2015: 729–742. (In Russ.).
51. Kraeva L.A., Tseneva G.Ya., Nikolaeva A.M., Alekseeva E.A. The role of highly antitoxic antibodies in the assessment of immunity to diphtheria infection. Epidemiology and infectious diseases. 2011; 4; 27–31. (In Russ.).
Review
For citations:
Briko N.I., Feldblyum I.V. The Modern Concept of Development of Vaccine Prevention in Russia. Epidemiology and Vaccinal Prevention. 2019;18(5):4-13. (In Russ.) https://doi.org/10.31631/2073-3046-2019-18-5-4-13
Views:
2977
Email this article 